Alzheimer’s Disease

NOMIS Award for Aguzzi

Adriano Aguzzi, professor and director of the Institute of Neuropathology at the University of Zurich, has been awarded for his research into neurodegenerative diseases [...]

March 3, 2019

Grants for Alzheimer’s research

Synapsis Foundation – Alzheimer Research Switzerland ARS announces a competition for Research Grants and Career Development Awards. Deadline for submission of proposals is [...]

July 1, 2018

New EIT Health projects in 2018

ETH Zurich is a partner in the European EIT Health Consortium. For 2018, three new projects with ETH participation will receive funding by the Consortium. In one of these [...]

October 1, 2017

Brain wellness

Alzheimer’s Disease, stroke and depression are among the most serious brain diseases. Lifestyle choices play an important role in their etiology. The new book by Hans-Ruedi [...]

October 1, 2017

Novel biomarker for AD

With the rapidly progressing development of therapies for Alzheimer’s Disease (AD) treatment, comes the need for sensitive diagnostics. Within the Oxford-McGill-ZNZ [...]

June 7, 2016

Rajendran receives SCOR Prize

Professor Lawrence Rajendran receives the SCOR Young Researcher European Grand Prize for his innovative research on Alzheimer’s disease (AD). Rajendran of the Systems and [...]

June 7, 2016

Specific inhibition of Aβ formation

BACE1, the enzyme involved in amyloid formation, is an important therapeutic target for Alzheimer’s Disease. Blocking BACE1 has, however, led to severe side effects. [...]

June 7, 2016

The immune system in AD

Dr. Maria Teresa Ferretti was awarded a three-year research grant from the Synapsis foundation to study the role of the immune system in Alzheimer’s disease. Together with [...]

June 7, 2016